| ²é¿´: 409 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
xiaowanzi9гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖúÒ»¶Î»°·Òëлл
|
|
|
These concems are covered in the proposed labeling and in approved labeling for approved doxycycline drug products. The statement is made in the proposed labeling and that for Vibramycin®that tetracyclines form stable calcium complexes in bone-forming tissue and can alter bone growth, although this may be reversible on discontinuation of the drug. The label states that the drug is included in Pregnancy Category D, based on a statistical1y significant association with fetal malformations in humans. The label also states that tetracyclines are secreted in human milk. |
» ²ÂÄãϲ»¶
ÉúÎïѧѧ˶Çóµ÷¼Á£º351·ÖÒ»Ö¾Ô¸ÄϾ©Ê¦·¶´óѧÉúÎïѧרҵ
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÏÃÃÅ´óѧ£¬ÉúÎïÓëÒ½Ò©£¬×Ü·Ö272£¬±¾¿Æ211
ÒѾÓÐ5È˻ظ´
µ÷¼Á
ÒѾÓÐ9È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
0703»¯Ñ§
ÒѾÓÐ18È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ5È˻ظ´
292Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´

ssssllllnnnn
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
Translator and Proofreader
- ·ÒëEPI: 1690
- Ó¦Öú: 452 (˶ʿ)
- ½ð±Ò: 31580.9
- ºì»¨: 100
- Ìû×Ó: 7681
- ÔÚÏß: 19966.6Сʱ
- ³æºÅ: 3328089
- ×¢²á: 2014-07-17
- רҵ: Ö×Áö·¢Éú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
RXMCDM: ½ð±Ò+1, ¶àлӦÖú£¡ 2014-10-14 22:06:17
xiaowanzi9: ½ð±Ò+20, ·ÒëEPI+1 2014-10-17 08:51:45
xiaowanzi9: »ØÌûÖö¥ 2014-10-20 10:09:36
RXMCDM: ½ð±Ò+1, ¶àлӦÖú£¡ 2014-10-14 22:06:17
xiaowanzi9: ½ð±Ò+20, ·ÒëEPI+1 2014-10-17 08:51:45
xiaowanzi9: »ØÌûÖö¥ 2014-10-20 10:09:36
|
ÕâЩÎÊÌâ¶¼º¸ÇÔÚÄâÒéµÄ±êÇ©ºÍÒѾÅú×¼Á˵ĶàÎ÷»·ËØÒ©Æ·µÄºË×¼±êʾÖС£¸ÃÉùÃ÷ÊǶÔËùÌá³öµÄ±êÇ©£¬Í¬Ê±Ò²¶ÔVibramycin®£¬£¨ÉùÃ÷±íʾ£©£¬ËÄ»·ËØÔÚ¹ÇÐγÉ×éÖ¯ÖпÉÒÔÐγÉÎȶ¨µÄ¸Æ¸´ºÏÎ²¢¿ÉÒԸıä¹Ç÷ÀµÄÉú³¤£¬¾¡¹ÜÍ£Ò©ºóÕâ×÷ÓÿÉÄÜÊÇ¿ÉÄæ¡£ ¸Ã±êǩָ³ö£¬»ùÓÚÆäÓëÈËÀàÌ¥¶ù»ûÐÎÓÐÏÔÖøÍ³¼ÆÑ§Ïà¹ØÐÔ£¬½«¸ÃÒ©Îï¹éÀàÓÚÈÑÉïDÀà¡£¸Ã±êÇ©»¹Ö¸³ö£¬ËÄ»·ËØ·ÖÃÚµ½ÈËÈéÖÖС£ |
2Â¥2014-10-13 21:58:30














»Ø¸´´ËÂ¥